Bill and Melinda Gates Foundation donations made to Seattle Biomedical Research Institute

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donor information

ItemValue
Country United States
Wikipedia pagehttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Best overview URLhttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Facebook username gatesfoundation
LinkedIn username bill-&-melinda-gates-foundation
Websitehttps://www.gatesfoundation.org/
Donations URLhttps://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database
Twitter usernamegatesfoundation
Page on philosophy informing donationshttps://www.gatesfoundation.org/What-We-Do
Grant application process pagehttps://www.gatesfoundation.org/How-We-Work/General-Information/Grantseeker-FAQ
Regularity with which donor updates donations datacontinuous updates
Regularity with which Donations List Website updates donations data (after donor update)irregular
Lag with which donor updates donations datamonths
Lag with which Donations List Website updates donations data (after donor update)years
Data entry method on Donations List WebsiteSQL insertion commands generated by script https://github.com/riceissa/gates-foundation-iati-processing

Brief history: The Gates Foundation launched in 2000, with precursors starting in the 1990s, financed by the personal wealth of co-founder Bill Gates from Microsoft. Starting 2005, it scaled up its giving significantly after a large funding commitment from Warren Buffett

Brief notes on broad donor philosophy and major focus areas: See https://www.gatesfoundation.org/Who-We-Are/General-Information/Foundation-Factsheet for the grantmaking areas. The four grantmaking areas are the Global Development Program, Global Health Program, Global Policy and Advocacy, and United States Program. Within the United States Program the focus is on K-12 education, the Internet, and emergency relief

Notes on grant publication logistics: Although the Gates Foundation has a grants database on its website, as well as individual grant pages for every grant, we use the IATI data instead, because it can be processed programmatically (the data on the site does not allow for full data download or easy programmatic processing). This leads to a few problems: first, IATI data does not include grants made in the United States, since it focuses on development assistance (DA) spending. Second, IATI data is updated more infrequently. Third, it may sometimes omit some information that is present in the grants database

Full donor page for donor Bill and Melinda Gates Foundation

Basic donee information

ItemValue
Country
Facebook page CIDResearch
Websitehttp://www.seattlebiomed.org/
Twitter usernameCIDResearch
Wikipedia pagehttps://en.wikipedia.org/wiki/Center_for_Infectious_Disease_Research
Instagram usernamecidresearch

Full donee page for donee Seattle Biomedical Research Institute

Donation amounts by cause area and year

If you hover over a cell for a given cause area and year, you will get a tooltip with the number of donees and the number of donations.

Note: Cause area classification used here may not match that used by donor for all cases.

Cause area Number of donations Total 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Global health (filter this donor) 33 68,278,832.06 -374,009.00 854,169.00 1,733,202.00 1,053,390.00 5,157,769.00 1,769,910.00 1,583,230.00 3,559,859.06 6,009,329.00 1,024,815.00 17,540,200.00 28,366,968.00
Total 33 68,278,832.06 -374,009.00 854,169.00 1,733,202.00 1,053,390.00 5,157,769.00 1,769,910.00 1,583,230.00 3,559,859.06 6,009,329.00 1,024,815.00 17,540,200.00 28,366,968.00

Graph of spending by cause area and year (incremental, not cumulative)

Graph of spending should have loaded here

Graph of spending by cause area and year (cumulative)

Graph of spending should have loaded here

Full list of donations in reverse chronological order (33 donations)

Amount (current USD)Donation dateCause areaURLInfluencerNotes
-374,009.002017-06-09Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- for the analysis of samples and data from Scientific Advisory Board-approved vaccine trials and natural history studies, in order to, as part of a Systems Biology/ Systems Immunology Consortium, uncover signatures, correlates, and mechanisms of protectio; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
848,669.002016-07-25Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to identify and develop new liver stage (LS)-directed interventions against malaria and interrogate underlying biology using novel assays and model systems; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
5,000.002016-02-17Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to provide for general operating support. 2016 Annual Gala for Global Health. Investment start date: 2/17/2016 to end date: 3/18/2016. Grantee name: Seattle Biomedical Research Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
500.002016-01-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide for general operating support. Starting Gates Thank You December 2015. Investment start date: 1/6/2016 to end date: 1/7/2016. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the).
1,724,702.002015-10-15Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to identify and develop new liver stage (LS)-directed interventions against malaria and interrogate underlying biology using novel assays and model systems; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
500.002015-09-30Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- To provide for general operating support. Starting Gates 4/8/2015. Investment start date: 9/30/2015 to end date: 10/29/2015. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the).
7,500.002015-08-25Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to provide general operating support. 2015 Gala for Global Health. Investment start date: 8/25/2015 to end date: 9/18/2015. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
500.002015-01-21Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to support the Starting Gates partnership. Starting Gates 10/15/14. Investment start date: 1/21/2015 to end date: 2/5/2015. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the).
1,043,390.002014-05-01Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to support the general operations of Seattle Biomedical Research Institute. General Operating Support. Investment start date: 5/1/2014 to end date: 12/31/2016. Grantee name: Seattle Biomedical Research Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
10,000.002014-02-13Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- for general operating support. 2014 Passport to Global Health Celebration. Investment start date: 2/13/2014 to end date: 3/7/2014. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the).
4,399,331.002013-10-18Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- for the analysis of samples and data from Scientific Advisory Board-approved vaccine trials and natural history studies, in order to, as part of a Systems Biology/ Systems Immunology Consortium, uncover signatures, correlates, and mechanisms of protectio; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
500.002013-09-26Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- for general operating support. StartingGates 9/17/2013. Investment start date: 9/26/2013 to end date: 10/25/2013. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the).
757,938.002013-05-24Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop methodology with the goal of identifying novel antigens that can induce sterile, long-lasting protection against malaria liver stage and thus infection; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
764,952.002012-10-11Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to facilitate identification of correlates of vaccine-induced immunity and (eventually) protection from TB, enabling iterative design of improved TB vaccines that will play a critical role in the fight to end this deadly disease.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
448,403.002012-08-14Global health/malariahttps://iatiregistry.org/publisher/bmgf-- for proteomic identification of novel surface and secreted antigens as targets to block malaria infection.; Aid type: Project-type interventions. Affected regions: South of Sahara.
556,555.002012-05-22Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop methodology with the goal of identifying further novel antigens that can induce sterile, long-lasting protection against malaria liver stage and thus infection; Aid type: Project-type interventions. Affected regions: South of Sahara.
1,203,410.002011-11-01Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to determine whether wild-type liver stage P. falciparum parasites can induce anti-infection immunity in humans if killed prior to the formation, and release of blood-stage parasites; Aid type: Project-type interventions. Affected regions: South of Sahara.
379,820.002011-10-31Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop tools that will enable the study of Plasmodium vivax malaria. Development of gametocyte and liver stage specific markers for Plasmodium vivax. Investment start date: 10/31/2011 to end date: 6/30/2014. Grantee name: Seattle Biomedical Research I; Aid type: Project-type interventions. Affected regions: South of Sahara.
1,423,943.622010-11-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop the knowledge which is needed to develop vaccines and drugs for global infectious diseases including malaria, tuberculosis, HIV/AIDS, and emerging and neglected diseases; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: South of Sahara|Developing countries, unspecified.
711,971.812010-11-18Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop the knowledge which is needed to develop vaccines and drugs for global infectious diseases including malaria, tuberculosis, HIV/AIDS, and emerging and neglected diseases; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: South of Sahara|Developing countries, unspecified.
711,971.812010-11-18Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop the knowledge which is needed to develop vaccines and drugs for global infectious diseases including malaria, tuberculosis, HIV/AIDS, and emerging and neglected diseases; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: South of Sahara|Developing countries, unspecified.
711,971.812010-11-18Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop the knowledge which is needed to develop vaccines and drugs for global infectious diseases including malaria, tuberculosis, HIV/AIDS, and emerging and neglected diseases; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: South of Sahara|Developing countries, unspecified.
3,005,236.002009-10-28Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to determine whether wild-type liver stage P. falciparum parasites can induce anti-infection immunity in humans if killed prior to the formation, and release of blood-stage parasites; Aid type: Project-type interventions. Affected regions: South of Sahara.
2,994,593.002009-08-27Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to fight tuberculosis by forging new ways to develop antibiotics that dramatically shorten therapy; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
9,500.002009-03-17Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- for general operating support. for general operating support. Investment start date: 3/17/2009 to end date: 3/17/2010. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
1,024,815.002008-09-26Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop new opportunities to identify and validate new targets for anti-malarial drugs; Aid type: Project-type interventions. Affected regions: South of Sahara.
8,998,623.002007-10-05Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop immunogens for a vaccine that will prevent pregnancy malaria globally. Pregnancy Malaria Initiative. Investment start date: 10/1/2007 to end date: 4/30/2014. Grantee name: Seattle Biomedical Research Institute; Aid type: Project-type interventions. Affected regions: South of Sahara.
1,021,401.002007-10-01Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to plan a Worldwide Antimalarial Drug Resistance Network (WARN) as a global resource to ensure efficacious use of antimalarial drugs; Aid type: Project-type interventions. Affected regions: South of Sahara.
7,520,176.002007-09-11Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to fight tuberculosis by forging new ways to develop antibiotics that dramatically shorten therapy; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
3,060,000.002006-08-04Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- for general operating support. Expansion Activities. Investment start date: 7/24/2006 to end date: 7/31/2012. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
2,970,000.002006-08-04Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- for general operating support. Expansion Activities. Investment start date: 7/24/2006 to end date: 7/31/2012. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
2,970,000.002006-08-04Global health/malariahttps://iatiregistry.org/publisher/bmgf-- for general operating support. Expansion Activities. Investment start date: 7/24/2006 to end date: 7/31/2012. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
19,366,968.002006-06-14Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to use novel computational and biological approaches for the design and evaluation of HIV vaccine candidates; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.